Last reviewed · How we verify

NCT07409337

Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms

Recruiting now NA Last updated 18 February 2026
What this trial tests

NA trial testing Self-Acupressure in Primary Dysmenorrhea in 120 participants. Currently enrolling.

Timeline
15 February 2026
Primary endpoint
15 August 2026
15 August 2026

Quick facts

Lead sponsorNigde Omer Halisdemir University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment120
Start date15 February 2026
Primary completion15 August 2026
Estimated completion15 August 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Nigde Omer Halisdemir University

Who can join

Adults 18 to 30, female only, with Primary Dysmenorrhea or Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Self-Acupressure

Trials testing the same drug.

Other recruiting trials for Primary Dysmenorrhea

Currently open trials in the same condition.

Other Nigde Omer Halisdemir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07409337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing